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AbstrAct
Objective The objective of this study was to compare 
ischaemic heart disease (IHD) mortality and risk factor 
burden across former Soviet Union (fSU) and satellite 
countries and regions in 1990 and 2015.
Methods The fSU and satellite countries were grouped 
into Central Asian, Central European and Eastern 
European regions. IHD mortality data for men and 
women of any age were gathered from national vital 
registration, and age, sex, country, year-specific IHD 
mortality rates were estimated in an ensemble model. 
IHD morbidity and mortality burden attributable to risk 
factors was estimated by comparative risk assessment 
using population attributable fractions.
results In 2015, age-standardised IHD death rates 
in Eastern European and Central Asian fSU countries 
were almost two times that of satellite states of Central 
Europe. Between 1990 and 2015, rates decreased 
substantially in Central Europe (men −43.5% (95% 
uncertainty interval −45.0%, −42.0%); women −42.9% 
(−44.0%, −41.0%)) but less in Eastern Europe (men 
−5.6% (−9.0, –3.0); women −12.2% (−15.5%, 
−9.0%)). Age-standardised IHD death rates also varied 
within regions: within Eastern Europe, rates decreased 
−51.7% in Estonian men (−54.0, −47.0) but increased 
+19.4% in Belarusian men (+12.0, +27.0). High blood 
pressure and cholesterol were leading risk factors for IHD 
burden, with smoking, body mass index, dietary factors 
and ambient air pollution also ranking high.
conclusions Some fSU countries continue to 
experience a high IHD burden, while others have 
achieved remarkable reductions in IHD mortality. Control 
of blood pressure, cholesterol and smoking are IHD 
prevention priorities.
IntrOductIOn
The fall of Communism from 1987 to 1994 had a 
calamitous effect on health in former Soviet Union 
(fSU) member and satellite countries. Life expec-
tancy plummeted in fSU countries, increasing the 
health gap with the rest of Europe. Since the early 
1990s, however, some fSU and former satellite 
countries have fared better than others in terms 
of all-cause mortality.1 For example, although life 
expectancy in former Soviet satellite countries of 
Central Europe had stagnated or declined in the late 
1980s, it improved steadily following the collapse 
of the Berlin Wall. After 1998, life expectancy in 
the Baltic countries of the fSU improved consis-
tently, both leading up to and after their joining the 
European Union in 2004.2
Ischaemic heart disease (IHD) was a leading 
contributor to the East-West health gap observed in 
Europe in the early 1990s.3 However, IHD burden 
across all the countries of the region in the years 
since 1990 has not been compared at the national 
level, using a standardised method. The Global 
Burden of Disease, Risk Factors, and Injuries 2015 
Study (GBD 2015 Study)4–7 produced estimates 
of fatal and non-fatal IHD burden and IHD risk 
factors for each fSU and former satellite country in 
the years 1990 and 2015. We set out to compare 
2015 IHD mortality across countries, change in 
IHD mortality between 1990 and 2015, and rela-
tive ranking of burden of disease attributable to 
IHD risk factors in fSU and satellite countries and 
the GBD regions including them (Central Asia, 
Central Europe, Eastern Europe).
MethOds
The fSU and satellite countries (ie, formally inde-
pendent but heavily under Soviet control politi-
cally and economically) were defined as Armenia, 
Azerbaijan, Georgia, Kazakhstan, Kyrgyzstan, 
Mongolia, Tajikistan, Turkmenistan and Uzbekistan 
(Central Asian countries); Albania, Bulgaria, Czech 
Republic, Hungary, Poland, Romania and Slovakia 
(Central European countries); Belarus, Estonia, 
Latvia, Lithuania, Moldova, Russia and Ukraine 
(Eastern European countries). Bosnia and Herze-
govina, Croatia, Macedonia, Montenegro, Serbia 
and Slovenia were included in this analysis as part 
of the Central Europe region.
GBD IHD burden estimation methods are 
described in detail in the online supplementary 
file 1 and in other published sources.4–7 The GBD 
2015 Study estimated IHD deaths and burden. 
Burden is quantified in disability-adjusted life years 
(DALYs). DALYs are composed of years of life lost 
(YLL) to premature deaths (mortality) and years 
lived with non-fatal disease disability (years lost 
due to disability, morbidity). YLL were calculated in 
relation to hypothetical age-specific reference life 
expectancies (eg, 86.6 years at birth) derived from 
life table methods.
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IHD has been consistently defined as an underlying cause of 
death across International Classification of Diseases (ICD) revi-
sions (most recently ICD-10 I20-I25, ICD-9 410-414).8 The 
GBD systematically reallocated proportions of ill-defined or 
erroneously assigned deaths to IHD based on the total distribu-
tion of actual causes of death by the country, sex, age and year.9 
Mortality data were mapped to GBD cause categories and distri-
bution of deaths to IHD and other causes and regional mortality 
and temporal trends were estimated using the cause of death 
ensemble modelling (CODEm) approach (see online supplemen-
tary file 1).10 The cause of death correct (CoDCorrect) algo-
rithm estimated total cardiovascular diseases as a proportion 
of all deaths, by which IHD deaths fit into the total cardiovas-
cular disease mortality envelope. Because heart failure is not 
defined as an underlying cause of death in the ICD classification 
system, separate methods were developed in order to distribute 
heart failure deaths to IHD and other upstream causes of heart 
failure.11
Rates of non-fatal IHD prevalence, incidence and excess 
mortality (non-fatal myocardial infarction (MI), angina and 
ischaemic heart failure) were estimated from rates found in a 
systematic review of epidemiologic literature using a Bayesian 
metaregression method (DisMod-MR, see online supplemen-
tary file 1).12 The literature review of IHD epidemiology studies 
was first conducted in 2010 (for papers published between 
1980 and 2008) and later updated to include all papers published 
betwen 2008 and 2015 (see online supplementary file 1). Papers 
identified in an all-world-regions electronic search for IHD 
epidemiology studies were initially selected if they reported on 
one of the epidemiologic parameters of interest (IHD death, 
acute MI, angina, or ischaemic heart failure incidence, preva-
lence, case fatality or mortality) and were population based. Fifty 
papers were included in the DisMod IHD model from the fSU 
and satellite state regions. Data for chronic IHD and post-MI 
survivors in Poland were added from the Prospective Rural and 
Epidemiological Study.13 In addition to published studies iden-
tified in the systematic review, the WHO World Health Survey 
provided data on angina prevalence, hospital admission registries 
and administrative data provided heart failure data, and unpub-
lished IHD surveillance data for years following 1994 were 
provided from the WHO Multinational Monitoring of Trends 
and Determinants in Cardiovascular Disease (MONICA) surveil-
lance site in Kaunas, Lithuania. Disability from each case of MI, 
angina, heart failure and other diseases or injuries was estimated 
in household surveys of laypeople in Bangladesh, Indonesia, 
Peru, Tanzania, the USA, Hungary, Italy, the Netherlands and 
Sweden, and an international web-based survey of health profes-
sionals.14 Angina symptom severity (mild, moderate or severe) 
was characterised according to the Canadian Cardiovascular 
Society classification15 and angina and heart failure symptom 
severity distributions were based on Short Form 12 quality of 
life scores in the US Medical Expenditure Panel Survey.
One thousand draws were taken of the posterior distributions 
of model covariate effects (beta coefficients), sampling error 
and data manipulations of CODEm and DisMod estimates, and 
model selection uncertainty of CODEm estimates. These uncer-
tainty estimates reflect Bayesian credible intervals as opposed 
to CIs. Both approaches yield similar numerical results in large 
samples.16 Ninety-five per cent uncertainty intervals reported 
in the paper represent the 2.5 and 97.5 percentiles of these 
posterior distributions. IHD burden in the GBD 2015 Eastern 
Europe, Central Asia and Central Europe regions and at the 
country level is reported as age-standardised death rates and 
DALYs per 100 000 people. A GBD standard population4 was 
used to age standardise rates using the direct method. Age-stan-
dardised death rates for each year between 1990 and 2015 were 
also plotted.
The Comparative Risk Assessment arm of the GBD 2015 esti-
mated the burden of IHD attributable to risk factors.17 National 
and subnational risk factor surveys were analysed in order to esti-
mate the distribution of exposure to each risk factor. An optimal, 
theoretical minimum risk exposure level was selected and the 
relative risk per unit of risk factor exposure was obtained from 
meta-analyses. Minimum risk exposure levels for cardiometa-
bolic risk factors were based on analysis of pooled prospective 
cohort studies and represent theoretical exposure levels at which 
risk is minimised (eg, systolic blood pressure (SBP) ~115 mm 
Hg) rather than the results of any known intervention that 
reduces risks. Attributable burden for every individual risk was 
calculated using the population attributable fraction method. 
The main risk factor clusters were hazardous alcohol consump-
tion, tobacco consumption, low physical activity, physiological 
factors (high fasting plasma glucose, high total cholesterol, high 
blood pressure, high body mass index (BMI)), diet (diet low 
in fruits, diet low in vegetables, diet low in whole grains, diet 
low in nuts and seeds, diet high in processed meat, diet high in 
sugar-sweetened beverages, diet low in fibre, diet low in seafood 
omega-3 fatty acids, diet low in polyunsaturated fatty acids, 
diet high in trans fatty acids, diet high in sodium), air pollution 
(ambient particulate matter pollution or household air pollution 
from solid fuels) and other environmental risks (lead exposure). 
The total burden of risks under each cluster was calculated 
assuming independent effect of risks except for some risks for 
which the total burden was corrected by the amount of overlap 
and mediated effect through other risks (eg, some part of burden 
of elevated BMI was assumed to be mediated through elevated 
SBP).7 Smoking was defined as prevalence of daily tobacco 
smoking and number of cigarettes smoked per day, with a lag 
in effect applied. Country-level alcohol exposure was estimated 
by way of national level consumption (mean litres of alcohol 
consumed per capita annually) and the distribution of daily 
alcohol intake among alcohol drinkers. For the GBD 2015, the 
association of alcohol consumption with IHD included both an 
average daily intake effect and a binge/episodic drinking effect.7 
Binge/episodic drinking pattern is more prevalent in countries 
of Eastern Europe and so a stronger adverse effect of alcohol, 
on a per capita basis, was estimated for those countries based on 
evidence from Russia.18 IHD risk factors were ranked in terms 
of attributable IHD morbidity burden (number of IHD DALYs).
results
In 2015, mean age-standardised IHD mortality per 100 000 men 
was almost twice as high in Eastern Europe (444.9) and Central 
Asia (425.2) compared with Central Europe (234.0). Among 
women, a similar pattern was observed, with rates almost twice 
as high in Eastern Europe (252.1) and Central Asia (271.1) as 
in Central Europe (141.3). Countries’ 2015 IHD burden varied 
within each region: age-standardised IHD death rates and IHD 
DALYs per 100 000 varied for both men and women among 
countries by at least 1.5 times in each region (comparing highest 
and lowest IHD burden countries within each of the three 
regions, figure 1, table 1, see online supplementary file 1).
Between 1990 and 2015, IHD death rates decreased most 
steeply in Central European men (median per cent change 
−43.5 (95% uncertainty interval −45.0, –42.0)) and women 
(−42.9 (−44.0, −41.0)) and proportionally less in Eastern 
European men (−5.6% (−9.0%, −3.0%)) and women (−12.2% 
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(−15.0, –9.0)) and Central Asian men (−11.9% (−15.0, –8.0)) 
and women (−16.5% (−20.0, −13.0)).
At the national level, mortality trends varied among the fSU 
and satellite countries in 5-year periods over the interval 1990–
2015 (figure 2). In Eastern Europe, age-standardised IHD 
mortality rates increased in all fSU countries in the early 1990s, 
after the fall of the Soviet Union. There was significant hetero-
geneity in overall change in age-standardised IHD death rate 
over time among countries within each region between 1990 
and 2015 (table 1). Within Eastern Europe, male IHD death 
rates decreased markedly in Estonia (median per cent change 
−51.7% (−54.0, –47.0)) and Latvia (−37.0% (−40.0, −34.0)), 
with decreases in all other Eastern European countries except 
for Belarus and Ukraine, which experienced large increases 
(+19.4% (+12.0, +27.0) and +13.5% (9.0, 19.0) respec-
tively). In Central Asia, the male IHD death rate decreased in 
all but Kyrgyzstan and Mongolia. The largest relative declines 
in male country-level age-standardised IHD death rate were 
observed in Central Europe; Central Europe and Estonia saw 
the largest declines in female rates. Age-standardised per capita 
IHD DALY decreases were seen in every country except for 
Belarus, Ukraine, Kyrgyzstan and Mongolia (for men) and 
Figure 1 Age-standardised ischaemic heart disease mortality per 100 000 people, former Soviet Union and satellite state territories, 2015. (A) 
Women. (B) Men (produced using ArcGIS and Global Burden of Disease 2015 data).
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table 1 (A) Women, country level estimates of age-standardised IHD death rates per 100 000 people in 1990 and 2015, and per cent change 
over time, by country and region. (B) Men, country level estimates of age-standardised IHD death rates per 100 000 people in 1990 and 2015, and 
per cent change over time, by country and region
(A) Women
1990 2015 Median % 
change 95% uIMean 95% uI Mean 95% uI
central Asia
  Armenia 297.0 276.5 317.0 201.5 184.2 221.4 −32.1% −38.0% −26.0%
  Azerbaijan 459.9 439.0 479.2 268.2 250.5 286.5 −41.8% −46.0% −37.0%
  Georgia 324.0 303.7 343.5 192.9 177.2 211.3 −40.6% −47.0% −33.0%
  Kazakhstan 283.1 273.9 291.1 267.5 245.5 290.5 −5.5% −14.0% 3.0%
  Kyrgyzstan 278.7 262.7 296.1 308.0 287.3 327.6 10.7% 1.0% 21.0%
  Mongolia 315.2 280.1 352.9 259.7 232.7 293.9 −17.9% −29.0% −5.0%
  Tajikistan 311.6 292.5 329.8 277.6 256.6 302.1 −11.1% −18.0% −3.0%
  Turkmenistan 388.4 377.4 399.5 332.5 316.8 349.7 −14.6% −19.0% −10.0%
  Uzbekistan 350.1 327.2 374.1 308.4 276.3 333.3 −11.7% −22.0% −3.0%
All 324.9 316.5 332.6 271.1 259.2 282.1 −16.5% −20.0% −13.0%
central europe
  Albania 128.4 119.1 140.0 126.1 113.8 139.3 −1.7% −15.0% 11.0%
  Bosnia and Herzegovina 196.1 181.3 211.0 88.5 77.5 100.5 −54.9% −61.0% −47.0%
  Bulgaria 283.8 275.5 292.5 188.8 178.1 199.9 −33.6% −38.0% −29.0%
  Croatia 186.5 179.2 194.2 139.1 131.2 146.8 −25.4% −30.0% −20.0%
  Czech Republic* 257.3 249.1 265.7 146.7 140.0 153.1 −43.0% −46.0% −40.0%
  Hungary 227.6 220.7 234.7 155.4 147.2 164.5 −31.8% −36.0% −27.0%
  Macedonia 154.7 142.8 167.2 117.2 105.6 129.8 −24.2% −33.0% −14.0%
  Montenegro 129.4 113.0 146.4 112.1 98.5 126.3 −13.3% −28.0% 4.0%
  Poland 271.8 265.0 279.0 121.1 115.5 127.0 −55.4% −58.0% −53.0%
  Romania 249.2 241.8 256.6 161.0 152.2 170.6 −35.4% −39.0% −31.0%
  Serbia 196.6 181.3 214.4 141.0 131.7 151.5 −28.0% −36.0% −21.0%
  Slovakia 306.7 294.7 317.4 174.4 165.8 183.1 −43.2% −46.0% −40.0%
  Slovenia 126.1 119.4 132.8 67.4 62.1 72.6 −46.6% −51.0% −42.0%
All 247.3 243.5 251.4 141.3 137.7 144.9 −42.9% −44.0% −41.0%
eastern europe
  Belarus 315.1 303.1 326.7 309.6 292.1 326.6 −1.8% −8.0% 5.0%
  Estonia 301.4 293.3 310.2 153.2 141.5 163.9 −49.1% −53.0% −45.0%
  Latvia 289.0 279.6 298.4 177.7 169.2 187.0 −38.5% −42.0% −35.0%
  Lithuania 307.5 300.7 314.1 181.3 174.4 188.2 −41.0% −43.0% −38.0%
  Moldova 384.2 374.8 393.3 276.8 266.0 288.3 −28.0% −31.0% −25.0%
  Russia 270.0 262.6 277.8 221.3 212.0 231.1 −18.1% −22.0% −14.0%
  Ukraine 317.9 310.3 325.2 340.5 324.7 356.5 7.1% 2.0% 13.0%
All 287.2 281.4 292.9 252.1 244.6 259.8 −12.2% −15.0% −9.0%
(b) Men
1990 2015 Median % 
change 95% uIMean 95% uI Mean 95% uI
central Asia
  Armenia 430.7 409.5 452.5 348.1 325.7 370.8 −19.2% −25.0% −13.0%
  Azerbaijan 645.9 619.6 672.0 415.4 375.4 465.4 −36.0% −42.0% −28.0%
  Georgia 511.7 477.3 548.6 389.9 354.0 420.4 −23.8% −32.0% −16.0%
  Kazakhstan 451.7 438.9 463.6 435.5 400.3 471.2 −3.6% −12.0% 4.0%
  Kyrgyzstan 421.3 399.3 444.5 468.3 440.0 500.2 11.2% 3.0% 20.0%
  Mongolia 380.7 300.1 418.1 417.7 378.8 452.7 9.2% −1.0% 27.0%
  Tajikistan 413.7 388.2 460.2 338.0 305.5 395.8 −18.3% −25.0% −10.0%
  Turkmenistan 584.4 520.4 599.6 527.5 493.5 556.3 −9.8% −14.0% −5.0%
  Uzbekistan 478.3 448.5 510.4 452.1 419.8 486.1 −5.3% −13.0% 3.0%
All 482.3 470.3 494.2 425.2 408.6 442.4 −11.9% −15.0% −8.0%
central europe
  Albania 232.6 216.0 247.0 209.6 180.3 239.2 −9.6% −23.0% 4.0%
  Bosnia and Herzegovina 321.0 296.0 342.6 145.3 128.3 170.5 −54.9% −60.0% −49.0%
  Bulgaria 414.4 402.0 425.5 313.0 298.8 328.9 −24.6% −28.0% −20.0%
  Croatia 327.0 316.5 339.1 201.8 192.0 211.7 −38.3% −42.0% −35.0%
Continued
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Ukraine and Kyrgyzstan (for women) (online supplementary 
file 1).
Relative rank of IHD burden (DALYs) attributable to major 
risk factors varied among countries of Central Europe, Eastern 
Europe and Central Asia in 2015 (figure 3). For men and women 
in all regions, high blood pressure was the leading risk factor 
contributing to IHD DALYs, with high total cholesterol the 
second leading risk factor. Depending on the country, BMI or 
smoking was the third leading risk factor. Hazardous alcohol 
consumption did not rank in the top 10 risk factors in any of 
the three fSU regions when men of all ages were combined. For 
women, it was the sixth leading risk factor in Belarus, the eighth 
in Russia and the ninth in Ukraine, and in the Eastern European 
region as a whole. However, taking younger adults (ages 15–49 
years) alone, alcohol use was the seventh leading risk factor for 
male IHD DALYs in Belarus, Russia and Ukraine, and the eighth 
in Moldova, and for women alcohol ranked third in Belarus, 
fourth in Russia and Ukraine, and fifth in Moldova.19 Particu-
late matter (ambient air pollution) was among the 10 leading 
contributors to IHD DALYs for men and women in many coun-
tries, with dietary risk factors occupying the remaining leading 
risk factor positions.
dIscussIOn
While age-standardised IHD mortality rates fluctuated in fSU 
countries since 1990, most republics and satellite states expe-
rienced overall improvements in IHD mortality and morbidity 
since the breakup of the Soviet Union. In others, namely Belarus, 
Ukraine, Kyrgyzstan and Mongolia, per capita IHD burden 
increased. Despite recent favourable trends, countries of the 
fSU still experience IHD mortality rates almost twice as high 
as those of Central Europe, mirroring higher all-cause mortality 
compared with the rest of Europe.2 In the years following the fSU 
collapse, inflation rose, and by 1998 Russia suffered an economic 
crisis that spread to neighbouring countries and reversed health 
gains won between 1991 and1994. The Baltic Republics were 
less affected by the 1998 crisis and health indicators in these 
countries continued to improve after it.2 Low socioeconomic 
status and unstable employment,1 unrewarding employment,20 
lack of social capital,1 21 community disengagement22 and wide-
spread feelings of alienation and low personal control23 have all 
been linked to poor health in the fSU. In Russia, depression has 
been directly linked to unfavourable cardiovascular disease risk 
factors, and mood symptoms were strong predictors of mortality 
among patients with arterial hypertension and IHD.24
The overall pattern of IHD mortality that we observed in fSU 
countries between 1990 and 2015 is similar to that observed 
for life expectancy at birth for these countries (life expectancy 
source: WHO Health for All Database; online supplementary file 
1). For example, in Eastern Europe, there was a large drop in life 
expectancy in all countries in the region in 1994, which corre-
sponds to increases in IHD mortality in those countries that year. 
In Russia, IHD mortality began to increase again in 1998 and 
only fell to pre-1998 levels in 2006, which again corresponds to 
the pattern observed for life expectancy in that country.
The leading more proximal cause of high IHD burden in 
the fSU and satellite countries was uncontrolled high blood 
pressure. While high alcohol and dietary salt consumption and 
low consumption of fresh fruits and vegetables may contribute 
to high blood pressure, there is also broad variation in the 
capacity of national health systems to detect, treat and control 
hypertension in clinical practice. In the years since the fSU 
breakup, former member countries have engaged in health 
system reforms to varying degrees (some of these reforms 
more successful than others); however, state funding for 
healthcare remains almost universally insufficient and patient 
out-of-pocket (OOP) payments (formal and informal) may act 
as one barrier to accessing medicines for controlling hyperten-
sion and chronic IHD.25 26 Of adults in the region prescribed 
treatment for hypertension, almost two-thirds report not 
taking treatment daily.27 To effectively provide services and 
protect patients from catastrophic expenditure, it is recom-
mended that public (or government) health expenditure as a 
proportion of GDP be at least 5%,28 and private (or OOP) 
(b) Men
1990 2015 Median % 
change 95% uIMean 95% uI Mean 95% uI
  Czech Republic 464.1 452.8 476.0 226.2 217.8 234.9 −51.2% −53.0% −49.0%
  Hungary 406.3 395.3 416.9 243.0 229.6 255.6 −40.2% −44.0% −37.0%
  Macedonia 256.6 237.7 275.3 201.6 180.8 222.4 −21.4% −30.0% −13.0%
  Montenegro 239.8 216.3 265.4 227.3 202.5 253.2 −5.0% −18.0% 10.0%
  Poland 505.0 494.1 515.3 223.5 215.1 232.0 −55.7% −58.0% −54.0%
  Romania 369.0 357.2 378.3 267.5 253.9 281.8 −27.5% −31.0% −23.0%
  Serbia 290.7 265.1 313.1 209.3 195.3 222.3 −27.8% −35.0% −20.0%
  Slovakia 512.7 494.1 530.2 268.4 254.1 280.9 −47.5% −51.0% −45.0%
  Slovenia 226.0 216.2 236.4 107.1 99.2 115.2 −52.7% −56.0% −49.0%
All 414.3 407.5 419.4 234.0 228.9 239.5 −43.5% −45.0% −42.0%
eastern europe
  Belarus 498.3 475.6 515.2 595.0 557.8 627.4 19.4% 12.0% 27.0%
  Estonia 538.5 525.2 551.5 261.1 245.5 287.3 −51.7% −54.0% −47.0%
  Latvia 515.6 502.4 528.3 325.3 312.1 341.1 −37.0% −40.0% −34.0%
  Lithuania 480.6 471.3 489.9 336.3 324.9 351.2 −30.1% −32.0% −27.0%
  Moldova 500.8 489.1 511.0 404.3 391.1 418.3 −19.2% −22.0% −16.0%
  Russia 458.8 446.3 473.0 405.3 390.7 419.6 −11.6% −16.0% −8.0%
  Ukraine 480.8 467.8 493.0 545.9 523.7 567.7 13.5% 9.0% 19.0%
All 471.8 461.5 482.4 444.9 433.3 456.5 −5.6% −9.0% −3.0%
IHD, ischaemic heart disease; UI, uncertainty interval.
table 1 Continued 
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expenditure on health occupy less than 15% of a country’s 
total health expenditure.29 Very few of the fSU countries 
included in our analysis meet these standards—for example, 
in Belarus, in 2014 public health expenditure was only 4% 
of GDP and OOP expenditure occupied 32% of total health 
expenditure; in Kyrgyzstan these figures are 4% and 39%, in 
Ukraine 4% and 46%. In the Czech Republic on the other 
hand, where an almost 50% reduction in male IHD mortality 
was observed, these figures are 6% and 14%.30
Hazardous alcohol consumption has been frequently impli-
cated as a cause of high IHD mortality in Eastern Europe, 
particularly in Russia.31 The episodic heavy drinking pattern, 
sometimes referred to as ‘binge’ drinking, is relatively 
common in fSU countries,21 and is linked to increased risk of 
IHD mortality and morbidity.32 Hazardous alcohol consump-
tion was an important IHD risk factor in Eastern European 
younger adults (aged 19–49 years) in our analysis. Nonetheless, 
the underlying mechanisms responsible for the link between 
alcohol and IHD deaths (or deaths classified as IHD) in the 
fSU remain controversial, and evidence suggests that this link 
contributes to most temporal fluctuations in mortality, but is 
not necessarily the main driver of an underlying steady state of 
high IHD mortality.33 While it appears that hazardous alcohol 
consumption is associated with the non-MI portion of IHD 
deaths, it remains unclear if this association is mediated by 
atherosclerotic plaque rupture in a coronary artery, alcohol-in-
duced arrhythmias or alcohol–related cardiomyopathy,34 and 
how much of the association is confounded by tobacco use in 
heavy alcohol consumers.35 Misclassification of alcohol-related 
deaths as IHD deaths might overestimate the number of IHD 
deaths, resulting in inaccurately high estimated IHD mortality 
rates in countries with high per capita alcohol consumption.
limitations
For a number of countries analysed, especially the countries 
of Central Asia, IHD epidemiological data were limited. Very 
few of the studies providing data on non-fatal burden of IHD 
in the fSU and satellite states included women. For example, 
only a fifth of papers (n=14) identified in initial screening 
for the Eastern Europe IHD literature review collected or 
Figure 2 Annual country-level age-standardised ischaemic heart disease mortality rate per 100 000 people trends by region, men and women, 
1990–2015. (A) Eastern Europe. (B) Central Asia. (C) Central Europe. Black line in each panel represents regional average (produced using R and 
Global Burden of Disease 2015 data).
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analysed data on women in their analyses. The under-repre-
sentation of women in epidemiological studies in the fSU is 
especially problematic given the large variation in IHD risk 
factor behaviour (ie, drinking and smoking) between women 
of different fSU countries, and between women and men in 
this region.36 Our conclusions regarding IHD risk factors 
are useful for guiding health policy but do not represent 
the impact of interventions to address these risks. Further 
research is needed to identify which interventions will 
provide most health benefit and societal value in reducing 
attributable burden for each risk factor.
cOnclusIOns
Our analysis shows substantial variations in IHD mortality 
among the fSU and satellite countries from 1990 to 2015. 
The markedly different age-standardised IHD mortality 
trends in these countries call for a greater focus on interven-
tions targeting IHD risk factors, but also the underlying social 
Figure 3 GBD 2015 Study ‘heat maps’ of risk factors ranked by attributable ischaemic heart disease disability-adjusted life years, 2015, 
age standardised, for men and women. (A) Women. (B) Men (produced using Excel and GBD 2015 data). GBD, Global Burden of Disease.
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mechanisms contributing to the IHD epidemic in the region. 
Reduced IHD rates achieved in neighbouring Central Euro-
pean and Baltic Republic countries could serve as road maps 
for fSU countries that are seeking to reverse the epidemic of 
IHD.
Key messages
What is already known on this subject?
Following the fall of the Soviet Union in 1991, age-adjusted 
all-cause mortality was substantially higher in the former Soviet 
Union (fSU) and its former satellite states than in the rest of 
Europe. Subsequently, the health gap between some fSU or 
satellite states and the rest of Europe narrowed, but for other 
countries the gap persisted. Past research implicated ischaemic 
heart disease (IHD) as an important contributor to the East-West 
Europe health gap in the early 1990s, and focused predominantly 
on hazardous alcohol consumption and smoking as causes.
What might this study add?
We examined patterns in IHD mortality in the fSU from 1990 
to 2015 and the contribution of risk factors to IHD burden. Our 
results show that death rates in Eastern European and Central 
Asian fSU countries in 2015 were almost two times that of the 
former satellite states of Central Europe. Between 1990 and 
2015, the relative median decrease in male age-standardised 
IHD death rates in Central Europe was −43.5%, compared with 
only −5.6% in Eastern Europe. Temporal IHD mortality trends 
varied among countries within regions. High blood pressure and 
high cholesterol rank as the first and second-leading risk factors 
responsible for IHD burden in the fSU, but smoking, dietary and 
ambient air pollution also rank in the top 10.
how might this impact on clinical practice?
Our results indicate that clinical practice should prioritise 
treatment and control of traditional IHD risk factors like high 
blood pressure, high cholesterol and smoking in fSU countries. 
Controlling the IHD epidemic in the fSU will also require public 
health measures to limit the harms of ambient air pollution and 
hazardous alcohol consumption.
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